Smart Ring Giant Oura Pulls $2.2 Billion IPO as Market Turbulence Bites

A Blockbuster IPO Hits the Brakes

Oura postponed its Nasdaq offering on September 29, just eight days after formally launching it. The decision blindsided many observers who had watched the Finnish smart ring maker build one of the most anticipated public debuts of the year. The company had planned to sell 50 million shares at $40 to $44 each, raising up to $2.2 billion at an implied valuation of about $15 billion.

The company announced it was postponing its previously announced initial public offering on the Nasdaq "despite strong demand, due to uncertainty in the IPO market." CEO Tom Hale said the company has "the luxury of choosing our moment," a confident stance that nevertheless underscores just how quickly market conditions can derail even the most well-positioned companies.

Strong Business, Rough Market

The frustrating part for Oura's backers? The company's fundamentals are hard to argue with. GAAP net income came in at $60.8 million for the nine months ending June 30, and Oura expects 90% revenue growth in fiscal 2026. Oura's valuation has risen fast in recent years — it was valued at about $11 billion last October when it raised $900 million in a round led by Fidelity, roughly double the $5.2 billion valuation it carried less than a year earlier.

Its business has also leaned increasingly into recurring revenue. Memberships carry an 89% gross margin and made up about 20% of sales in the latest period, though hardware still generates most of the revenue. Since its founding in 2013, the company says it has "amassed one of the largest and highest-quality longitudinal biometric datasets in consumer health" with nearly 42 billion hours of physiological data.

Broader Market Forces at Work

Oura isn't alone in pulling back. Renaissance analysts noted that "IPO activity in the third quarter of 2026 fell below expectations due to heightened concerns over AI spending, bond yields reaching a 19-year high, and the resumption of rate hikes, dampening the autumn recovery." Avery Marquez, director of investment strategies at Renaissance Capital, said "the recent spike in yields and resumed rate hikes have put some downward pressure on growth companies, and that's a majority of the companies in the IPO market."

Before Oura postponed its listing, nuclear component manufacturer Holtec Nuclear withdrew its IPO last Friday; materials company Amaero postponed its IPO the previous Wednesday; and Bamboo Insurance postponed its IPO on September 22. Oura's IPO postponement also comes after reports that AI developer Anthropic is delaying its IPO, likely until after the US midterm elections. Jay Ritter, head of the IPO Initiative at the University of Florida's Warrington College of Business, said: "I have some sympathy for using market conditions as an excuse — when three well-known companies do it, it clearly isn't just a company-specific issue."

What This Means for the Wearable Health Boom

Oura's subscription service, which costs $5.99 per month, had 5 million paid members as of June 2026, and 72% of its members are women, with 27% over age 45. The company, whose sensor-laden rings have adorned the hands of celebrities including Lady Gaga and Coco Gauff, wanted to raise up to $2.2 billion — money that would have fueled its next phase of growth in AI-driven health analytics. The firm promotes its plans to expand its use of AI and machine learning to make predictions and recommendations.

A consumer class action filed in August challenges the accuracy of Oura's sleep tracking, though the company says it stands behind its science, and the delay is understood to be unrelated. With bond yields elevated and rate hike fears lingering, Oura's IPO window remains firmly shut for now — but its underlying growth story hasn't changed. When markets stabilize, expect the company to move quickly. Oura had about $372 million in cash at the end of June, meaning it isn't desperate for a lifeline — it's simply waiting for the right moment to arrive.